Search
Search
About
Log in
Join
Experiences with
Clinical trials
Posts
Communities
15,882 public posts
Filter results
Things I Like About ADT
I know that no one, like NO ONE, actually wants to be on ADT. There are a lot of downsides to it, and complaints about the fatigue, lack of sex drive, etc. are a common theme on this forum. I'm about a year out now from starting on Zoladex shots (a drug that works in the same way as Lupron), and I
I know that no one, like NO ONE, actually wants to be on ADT. There are a lot of downsides to it, and complaints about the fatigue, lack of sex drive, etc. are a common theme on this forum. I'm about a year out now from starting on Zoladex shots (a drug that works in the same way as Lupron), and I
32Percenter
in
Advanced Prostate Cancer
6 months ago
FYI: from the VA research information on Veterans
➤ Prostate cancer Prostate cancer is the most common malignancy affecting men in the United States. It is also the most commonly diagnosed solid tumor in VA. In 2016, VA and the Prostate Cancer Foundation established a partnership to promote prevention, screening, and research to find new treatments
➤ Prostate cancer Prostate cancer is the most common malignancy affecting men in the United States. It is also the most commonly diagnosed solid tumor in VA. In 2016, VA and the Prostate Cancer Foundation established a partnership to promote prevention, screening, and research to find new treatments
MouseAddams
in
Advanced Prostate Cancer
6 months ago
Provenge Underway
Morning folks, Well I completed my first cycle of Provenge yesterday and all seems well so far. I also met with MO to review recent genetic testing results and have confirmed a mutation BRiP1 which is associated with autosomal dominant hereditary ovarian cancer, autosomal recessive Fanconia anemia,
Morning folks, Well I completed my first cycle of Provenge yesterday and all seems well so far. I also met with MO to review recent genetic testing results and have confirmed a mutation BRiP1 which is associated with autosomal dominant hereditary ovarian cancer, autosomal recessive Fanconia anemia,
Pmann
in
Advanced Prostate Cancer
6 months ago
Want to take advantage of all our features? Just log in!
Log in
or
Join
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC - MedPage Today, November 1, 2023
Modified dosing schedule from phase III randomized CABASTY trial for Jetvana (+ G-CSF) for older patients out of non-chemo treatment options. * * * [i]
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC - Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold
Modified dosing schedule from phase III randomized CABASTY trial for Jetvana (+ G-CSF) for older patients out of non-chemo treatment options. * * * [i]
Reduced-Dose Schedule of Cabazitaxel Viable for Seniors With mCRPC - Grade 3 or higher neutropenia, neutropenic complications reduced by 12-fold
CaptnMojoe
in
Fight Prostate Cancer
6 months ago
ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC
Looks like a number of Drug companies are creating drugs that interact with the AR’s N-terminal domain and ligand-binding domain, impeding cell growth and enabling AR degradation. ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC October 27, 2023 Investigators will assess
Looks like a number of Drug companies are creating drugs that interact with the AR’s N-terminal domain and ligand-binding domain, impeding cell growth and enabling AR degradation. ONCT-534 Earns FDA Fast Track Designation in R/R Metastatic CRPC October 27, 2023 Investigators will assess
Scout4answers
in
Advanced Prostate Cancer
6 months ago
Please join us tomorrow, April 18th, for our first back to in person and also online Living Room
Neal, MD, PhD, Stanford Cancer Institute, Associate Professor of Medicine, Division of Oncology, Medical Director for the Cancer
Clinical
Trials
Office.
Neal, MD, PhD, Stanford Cancer Institute, Associate Professor of Medicine, Division of Oncology, Medical Director for the Cancer
Clinical
Trials
Office.
Michelezeh
in
Small Cell Lung Cancer Support
1 year ago
Please join us tomorrow, April 18th, for our first back to in person and also online Living Room
Neal, MD, PhD, Stanford Cancer Institute, Associate Professor of Medicine, Division of Oncology, Medical Director for the Cancer
Clinical
Trials
Office.
Neal, MD, PhD, Stanford Cancer Institute, Associate Professor of Medicine, Division of Oncology, Medical Director for the Cancer
Clinical
Trials
Office.
Michelezeh
Partner
in
Lung Cancer Support
1 year ago
Combining the Influenza and COVID-19 vaccines.
I have read of some people who got both vaccines at the same time, and their experience was not good. However perhaps a different kind of Influenza vaccine combined with a COVID-19 vaccine might make things easier.? This approach is now being tested. Pfizer and BioNTech Announce Positive Topline
I have read of some people who got both vaccines at the same time, and their experience was not good. However perhaps a different kind of Influenza vaccine combined with a COVID-19 vaccine might make things easier.? This approach is now being tested. Pfizer and BioNTech Announce Positive Topline
Kwenda
in
CLL Support
6 months ago
Masofaniten +Enzalutamide This could be a game changer...Science is coming to our aid
This is a company that I was turned on to by Nalkrantz before he was removed from this board. He told me that he was in touch with a doctor that was involved with this drug. Reportedly the early testing on a single patient had been phenomenal. These are pretty amazing #s NEWS PROVIDED BY ESSA
This is a company that I was turned on to by Nalkrantz before he was removed from this board. He told me that he was in touch with a doctor that was involved with this drug. Reportedly the early testing on a single patient had been phenomenal. These are pretty amazing #s NEWS PROVIDED BY ESSA
Scout4answers
in
Advanced Prostate Cancer
6 months ago
Shingrix may be available on Australia's National Immunisation Program for those with CLL from 1 November 2023
[/i] [i]In
clinical
trials
, Zostavax efficacy was lower and decreased with increasing age (70% in people aged 50-59 years, 64% in those aged 60-69 years, 41% in 70-79 years, and 18% in 80-89 years (no longer statistically significant in this age group)."
[/i] [i]In
clinical
trials
, Zostavax efficacy was lower and decreased with increasing age (70% in people aged 50-59 years, 64% in those aged 60-69 years, 41% in 70-79 years, and 18% in 80-89 years (no longer statistically significant in this age group)."
CLLerinOz
Volunteer
in
CLL Support
10 months ago
Cognition Issues
My husband is going into year 7 with PC. He had prostate removed… at Mayo in 2017. All clear margins, contained etc. 6 months he had Biochemical Recurrence. Then radiation and cryptography on one node. Since then he has been intermittently on ADT until he because Castrate resistant about a year ago
My husband is going into year 7 with PC. He had prostate removed… at Mayo in 2017. All clear margins, contained etc. 6 months he had Biochemical Recurrence. Then radiation and cryptography on one node. Since then he has been intermittently on ADT until he because Castrate resistant about a year ago
JolleySprings
in
Advanced Prostate Cancer
6 months ago
ER+ PR+ HER2-
My dr was one of the clinicians for the
clinical
trials
of Ibrance when he was a breast cancer dr ( he switched Gyn cancers when came to the place where I get my care). So I was one of the very few endometrial cancer patients to receive it in the USA.
My dr was one of the clinicians for the
clinical
trials
of Ibrance when he was a breast cancer dr ( he switched Gyn cancers when came to the place where I get my care). So I was one of the very few endometrial cancer patients to receive it in the USA.
Merma
in
SHARE Ovarian Cancer Support
1 year ago
Annovis Bio Clinical Trials Update . . .
Strong interest being shown in Annovis Bio Parkinsons
clinical
trials
https://stocks.apple.com/A5Vy9P2FBSVmyh_y-Zvz_GQ
Strong interest being shown in Annovis Bio Parkinsons
clinical
trials
https://stocks.apple.com/A5Vy9P2FBSVmyh_y-Zvz_GQ
redhawk1
in
Cure Parkinson's
1 year ago
Clinical trials for AML
Hi. Since I had a abmt in July I have been visiting the hospital 3 times a week. I have become friendly with a couple and the wife who has aml is always needing platelets or something. Her transplant has been put on hold because of her blood levels and sadly their consultant is not being very informative
Hi. Since I had a abmt in July I have been visiting the hospital 3 times a week. I have become friendly with a couple and the wife who has aml is always needing platelets or something. Her transplant has been put on hold because of her blood levels and sadly their consultant is not being very informative
Kraskie1915
in
Leukaemia CARE
1 year ago
Update on Prostate Cancer Vaccines that I follow... another year is gone...
Greetings FPC forum, It has been another year... and I would love to have better news... there is a new vaccine candidate to monitor, but the reality is that the system takes time... The system needs a revision in my opinion, but I digress... As I reviewed the last time, the vaccine trial for RhoVac's
Greetings FPC forum, It has been another year... and I would love to have better news... there is a new vaccine candidate to monitor, but the reality is that the system takes time... The system needs a revision in my opinion, but I digress... As I reviewed the last time, the vaccine trial for RhoVac's
NPfisherman
in
Fight Prostate Cancer
6 months ago
Clinical Trial Dallas UT Southwestern
Will begin a Pfizer starting on Monday. I will post more later as it goes. We are adding a drug to Xtandi to treat solid tumors. I have been on and off Xtandi a few times. I am chemo naive. In the past had a very heavy tumor load and received 3 rounds of Lu-177 from Ishita Sen, Fortis health in Delhi
Will begin a Pfizer starting on Monday. I will post more later as it goes. We are adding a drug to Xtandi to treat solid tumors. I have been on and off Xtandi a few times. I am chemo naive. In the past had a very heavy tumor load and received 3 rounds of Lu-177 from Ishita Sen, Fortis health in Delhi
pilot52
in
Advanced Prostate Cancer
7 months ago
Care oncology
Hi I have stage 4 lung cancer and today have just found out that they are going to stop my immunotherapy as I have had to many side effects anyway my choices are to go back on chemo for a bit or I might be able to go a clinical trial. I've heard and read up a bit care oncology has anyone on here had
Hi I have stage 4 lung cancer and today have just found out that they are going to stop my immunotherapy as I have had to many side effects anyway my choices are to go back on chemo for a bit or I might be able to go a clinical trial. I've heard and read up a bit care oncology has anyone on here had
Leni22
in
The Roy Castle Lung Cancer Foundation
7 months ago
NICE Final Guidance on Ruxolitinib for the treatment of Polycythaemia Vera
We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has recently released Final Guidance recommending Ruxolitinib for treating Polycythaemia Vera (PV) in adults in England who cannot tolerate Hydroxycarbamide (also called Hydroxyurea) or when the condition is
We are delighted to announce that NICE (the National Institute for Health and Care Excellence) has recently released Final Guidance recommending Ruxolitinib for treating Polycythaemia Vera (PV) in adults in England who cannot tolerate Hydroxycarbamide (also called Hydroxyurea) or when the condition is
Mazcd
MPNVoice
in
MPN Voice
7 months ago
PT-112 Immunotherapy Trial
Hi fellow travelers, Maxone73posted this sumary of interesting developments yesterday: https://healthunlocked.com/advanced-prostate-cancer/posts/150097372/new-hopes-we-all-need-them-on-a-monday So I thought that I would raise my my hand and say “I’m on the trial!” It’s NCT02266745, and here’s the
Hi fellow travelers, Maxone73posted this sumary of interesting developments yesterday: https://healthunlocked.com/advanced-prostate-cancer/posts/150097372/new-hopes-we-all-need-them-on-a-monday So I thought that I would raise my my hand and say “I’m on the trial!” It’s NCT02266745, and here’s the
TeleGuy
in
Advanced Prostate Cancer
7 months ago
CAR T-cell therapy IMPT-514 gets FDA fast track designation for lupus
Investigational treatment targets active, resistant lupus nephritis and SLE The U.S. Food and Drug Administration (FDA) has granted fast track designation to IMPT-514, a CAR T-cell therapy being developed by Immpact Bio for people with active, treatment-resistant lupus nephritis and systemic lupus
Investigational treatment targets active, resistant lupus nephritis and SLE The U.S. Food and Drug Administration (FDA) has granted fast track designation to IMPT-514, a CAR T-cell therapy being developed by Immpact Bio for people with active, treatment-resistant lupus nephritis and systemic lupus
lupus-support1
Administrator
in
LUpus Patients Understanding and Support
7 months ago
1
...
19
20
21
...
100
Next page
10
20
30
40
50
60
70
80
90
100
Filter results
Clear filters
Posted in
All communities
Atrial Fibrillation Support
4073 results
Anxiety and Depression Support
2496 results
Advanced Prostate Cancer
1368 results
View top 10 communities
Sort by
Most Relevant
Newest